NEW YORK (May 10, 2024) – Dr. Myles Wolf, an esteemed physician-scientist who specializes in nephrology, has been appointed chair of the Joan and Sanford I. Weill Department of Medicine at Weill Cornell Medicine and physician-in-chief at NewYork-Presbyterian/Weill Cornell Medical Center, effective July 1.

Recruited as the Sanford I. Weill Chair, Dr. Wolf will lead the institutions’ largest clinical and academic department, overseeing 16 divisions and nearly 2,250 physicians and scientists—health care innovators and skilled experts in their areas of medicine. Dr. Wolf will seek to further enhance and expand the reach of Weill Cornell Medicine and NewYork-Presbyterian’s exceptional clinical care, while also broadening the department’s research portfolio. As chair, he will recruit leading clinicians and investigators to join the distinguished team already in place in the Weill Department of Medicine and foster the next generation of medical leaders through its education programs—including residency and fellowship programs in a range of specialties.

Dr. Wolf was recruited from Duke University School of Medicine, where he is chief of the Division of Nephrology and the Charles Johnson, MD Distinguished Professor of Medicine, also serving as the Nephrology Therapeutic Area Leader at the Duke Clinical Research Institute.

He succeeds Dr. Anthony Hollenberg, who led the Weill Department of Medicine from 2017 to 2022. Dr. John Leonard, senior associate dean for innovation and initiatives and the Richard T. Silver Distinguished Professor of Hematology and Medical Oncology, served as interim chair since October 2022.

“Dr. Wolf is a distinguished scientist, physician, educator and leader, and we are delighted that he will be joining our institutions as chair of the Weill Department of Medicine,” said Dr. Robert A. Harrington, the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine. “With Dr. Wolf at the helm, the department will continue to maintain its reputation of excellence, built on a foundation of cutting-edge research and innovation, world-class care and the cultivation of future health care leaders.”

“We are delighted to welcome Dr. Wolf, an outstanding physician-scientist, educator and leader who shares our commitment to providing the highest quality care to our patients,” said Dr. Steven J. Corwin, president and chief executive officer of NewYork-Presbyterian. “Dr. Wolf’s leadership and vision will be a tremendous asset to the department as we continue to advance care and research to improve the health of all the communities we serve.”

More People on the Move